PTPN12 is considered a promising therapeutic target for critical diseases such as cancer, diabetes, metabolic diseases, and autoimmune diseases and has been used for therapeutic intervention in acute myocardial infarction24,25. This evidence concerns the gene PTPN12 and autoimmune disease.